Medicis Sues Lupin To Halt Generic Acne Drug

By Leigh Kamping-Carder · February 3, 2010, 2:44 PM EST

Skin health specialist Medicis Pharmaceutical Corp. has hauled Lupin Ltd. into court over the Indian drugmaker's plan to manufacture generic versions of all five approved dosages of acne drug Solodyn....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Medicis Pharmaceutical Corporation v. Lupin Ltd. et al

Case Number

1:09-cv-03062

Court

Maryland

Nature of Suit

Patent

Date Filed

November 17, 2009